Skip to main content
OpenTrials

Clinical trial condition

Histiocytoma, Malignant Fibrous

Explore clinical trials studying Histiocytoma, Malignant Fibrous. Study availability and eligibility vary by location and protocol.

71 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Histiocytoma, Malignant Fibrous trial results

Terminated

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

NCT05827614

Conditions
Anogenital Cancer, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Sarcoma Oncology Santa Monica, California, United States
  • HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
View all 16 locations
View Trial Details

Related conditions